Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Triple Artemisinin-based Combination Therapy for Treatment of Uncomplicated Plasmodium Falciparum Malaria, Delay Drug Resistance Development of Plasmodium Falciparum in Tanzania: a Randomized Three Arm Clinical Trial

NCT05764746 is registered in ClinicalTrials.gov with Muhimbili University of Health and Allied Sciences as lead sponsor.

NCT NCT05764746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Triple Artemisinin-based Combination Therapy for Treatment of Uncomplicated Plasmodium Falciparum Malaria, Delay Drug Resistance Development of Plasmodium Falciparum in Tanzania: a Randomized Three Arm Clinical Trial
Lead sponsor
Muhimbili University of Health and Allied Sciences
Phase
Phase 2/3
Overall status
Completed
Start date
May 1, 2023
Completion date
January 1, 2025
Enrollment
384 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated plasmodium falciparum malaria